Dougherty's Pharmacy, Inc. (MYDP) financial statements (2021 and earlier)

Company profile

Business Address 5924 ROYAL LANE, SUITE 250
DALLAS, TX 75230
State of Incorp. DE
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments00
Cash and cash equivalents00
Receivables22
Inventory, net of allowances, customer advances and progress billings34
Inventory34
Prepaid expense00
Other undisclosed current assets 0
Total current assets:56
Noncurrent Assets
Property, plant and equipment11
Long-term investments and receivables, including:00
Other undisclosed long-term investments and receivables00
Intangible assets, net (including goodwill)23
Intangible assets, net (excluding goodwill)23
Other undisclosed noncurrent assets 2
Total noncurrent assets:46
TOTAL ASSETS:813
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34
Accounts payable33
Accrued liabilities00
Debt55
Total current liabilities:88
Noncurrent Liabilities
Long-term debt and lease obligation23
Long-term debt, excluding current maturities23
Total noncurrent liabilities:23
Total liabilities:1011
Stockholders' equity
Stockholders' equity attributable to parent(2)2
Common stock00
Treasury stock, value(0)(0)
Additional paid in capital6060
Accumulated deficit(62)(58)
Total stockholders' equity:(2)2
TOTAL LIABILITIES AND EQUITY:813

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
Revenues3640
Cost of revenue(27)(29)
Gross profit:911
Operating expenses(10)(11)
Operating loss:(1)(1)
Interest and debt expense(0)(0)
Loss from continuing operations before equity method investments, income taxes:(2)(1)
Other undisclosed income (loss) from continuing operations before income taxes0(0)
Loss from continuing operations before income taxes:(2)(1)
Income tax expense(2)(1)
Net loss available to common stockholders, diluted:(4)(2)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
Net loss:(4)(2)
Comprehensive loss, net of tax, attributable to parent:(4)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: